Illumina Inc

Find Ratings Reports
ILMN : NASDAQ : Health Care
$184.86 up 1.12 | 0.61%
Today's Range: 182.95 - 185.95
Avg. Daily Volume: 968700.0
04/28/17 - 4:00 PM ET

Financial Analysis


ILLUMINA INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ILLUMINA INC is extremely liquid. Currently, the Quick Ratio is 3.00 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.

At the same time, stockholders' equity ("net worth") has greatly increased by 28.42% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)598.0571.76
EBITDA ($mil)120.4157.75
EBIT ($mil)82.4124.53
Net Income ($mil)373.089.59


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)1778.01343.09
Total Assets ($mil)4598.03793.71
Total Debt ($mil)1056.01022.65
Equity ($mil)2557.01991.11


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin70.975.25
EBITDA Margin20.1327.58
Operating Margin13.7821.78
Sales Turnover0.530.59
Return on Assets16.2210.92
Return on Equity29.1720.81
Debt Q1 FY17 Q1 FY16
Current Ratio3.524.31
Debt/Capital0.290.34
Interest Expense0.08.53
Interest Coverage0.014.61


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)146.2147.2
Div / share0.00.0
EPS2.520.6
Book value / share17.4913.53
Institutional Own % n/a n/a
Avg Daily Volume934686.01476823.0

Valuation


BUY. The current P/E ratio indicates a significant discount compared to an average of 46.68 for the Life Sciences Tools & Services industry and a significant premium compared to the S&P 500 average of 25.26. For additional comparison, its price-to-book ratio of 10.38 indicates a significant premium versus the S&P 500 average of 3.03 and a significant premium versus the industry average of 6.11. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. The valuation analysis reveals that, ILLUMINA INC seems to be trading at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ILMN 35.94 Peers 46.68   ILMN 32.53 Peers 23.12

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

ILMN is trading at a discount to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ILMN is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ILMN 42.21 Peers 27.67   ILMN 1.90 Peers 0.94

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

ILMN is trading at a significant premium to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ILMN trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ILMN 10.38 Peers 6.11   ILMN 81.65 Peers 1.85

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ILMN is trading at a significant premium to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ILMN is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ILMN 10.94 Peers 37.40   ILMN 7.61 Peers 9.42

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ILMN is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ILMN trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades